Local Antibiotic Delivery for Community Acquired Pneumonia (LANDCAP-1)

NCT06859450 PHASE2, PHASE3 NOT_YET_RECRUITING

A randomized, double-blinded clinical pilot study to assess whether addition of inhaled levofloxacin 240 mg twice daily for three days leads to improved or worsened physiological status in CAP patients with and without pre-existing lung disease.

Details

Lead sponsor	Copenhagen Respiratory Research
Phase	PHASE2, PHASE3
Status	NOT_YET_RECRUITING
Enrolment	36
Start date	Tue Mar 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Sep 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Community Acquired Pneumonia (CAP)

Interventions

• Levofloxacin
• Placebo